Plexus (FRA:PX4) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PX4 Plexus Corp FRA:PX4
85 GF Score
Price €214.00
GF Value €128.28
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Plexus FFO?

FFO (Funds from operations) only applies to REITs.

FRA:PX4
85GF Score
Plexus Corp FRA:PX4
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Plexus (FRA:PX4) Overvalued in 2026?

Based on GuruFocus' analysis, Plexus stock appears to be overvalued. The current stock price of €214.00 is trading 66.8% above its estimated GF Value™ of €128.28. GuruFocus considers Plexus to be Significantly Overvalued.

Key valuation signals for FRA:PX4:

  • FFO:
  • GF Value™: €128.28 vs. price of €214.00 (66.8% above fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the FRA:PX4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Plexus Business Description

Other Exchanges PLXS:USA
Address One Plexus Way, P.O. Box 156, Neenah, WI, USA, 54956
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.
85GF Score

Get the complete analysis for FRA:PX4

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€214.00
Price
€128.28
GF Value